9999999995-23-002613.txt : 20230911
9999999995-23-002613.hdr.sgml : 20230911
20230911001533
ACCESSION NUMBER: 9999999995-23-002613
CONFORMED SUBMISSION TYPE: EFFECT
PUBLIC DOCUMENT COUNT: 1
FILED AS OF DATE: 20230908
DATE AS OF CHANGE: 20230911
EFFECTIVENESS DATE: 20230908
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Taysha Gene Therapies, Inc.
CENTRAL INDEX KEY: 0001806310
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 843199512
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: EFFECT
SEC ACT: 1933 Act
SEC FILE NUMBER: 333-274264
FILM NUMBER: 231246562
BUSINESS ADDRESS:
STREET 1: 3000 PEGASUS PARK DRIVE
STREET 2: SUITE 1430
CITY: DALLAS
STATE: TX
ZIP: 75247
BUSINESS PHONE: (214) 612-0000
MAIL ADDRESS:
STREET 1: 3000 PEGASUS PARK DRIVE
STREET 2: SUITE 1430
CITY: DALLAS
STATE: TX
ZIP: 75247
EFFECT
1
primary_doc.xml
X0101
EFFECT
33
LIVE
2023-09-08
16:00:00
0001806310
Taysha Gene Therapies, Inc.
333-274264